Pallet, N <br/><br/>
Long-Term Clinical Impact of Adaptation of Initial Tacrolimus Dosing to CYP3A5 Genotype.  [electronic resource] 

 -  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons  09 2016 
 - 2670-5 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1600-6143 
<br/><br/><label>Standard No.: </label>10.1111/ajt.13788  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cytochrome P-450 CYP3A--genetics<br/>Dose-Response Relationship, Drug<br/>Female<br/>Follow-Up Studies<br/>Genotype<br/>Glomerular Filtration Rate<br/>Graft Rejection--drug therapy<br/>Graft Survival<br/>Humans<br/>Immunosuppressive Agents--pharmacokinetics<br/>Kidney Failure, Chronic--genetics<br/>Kidney Function Tests<br/>Kidney Transplantation--adverse effects<br/>Male<br/>Middle Aged<br/>Pharmacogenetics<br/>Prognosis<br/>Prospective Studies<br/>Risk Factors<br/>Tacrolimus--administration & dosage<br/>Tissue Distribution